Wolfson Guest Lecture: Professor Marcel Tanner, Director, Swiss Tropical and Public Health Institute
The Wolfson Research Institute is delighted to welcome Professor Marcel Tanner, Director of the Swiss Tropical and Public Health Institute on 16th June 2011.
Professor Tanner's lecture is entitled "Challenges for Global Health - from diseases to health systems".
Most of the burden of diseases and ill-health associated with global change is localized in resources constraint countries of which sub-Saharan Africa will face a very large share. This in turn will result in increasing poverty and hence will also and directly impact on wealthier countries. We will briefly examine the evidence with regards to potential effects of key determinants of global change on health and disease, such as climate, urbanization, migration and mobility of populations, deforestation, water use and re-use, agricultural patterns and pollution. Special emphasis will be placed on the diseases of poverty and the neglected tropical diseases. Four levels of the challenges will be discussed: (i) The development of new tools and strategies for disease control and elimination, (ii) the involvement of the people and societies concerned, (iii) translating health systems thinking into public and international health practice, and (iv) translational research and effective partnerships.
Marcel Tanner obtained his PhD on medical biology from the University of Basel and a MPH from the University of London. He is Director of the Swiss Tropical- and Public Health Institute, Basel (until 1.2010: Swiss Tropical Institute) and Professor of Epidemiology and Medical Parasitology at the University of Basel and at the Federal Institute of Technology. Since 1977, his research ranges from basic research on the cell biology and immunology on malaria, schistosomiasis, trypanosomiasis and filariasis to epidemiological and public health research on risk assessment, vulnerability, health impact and district health planning. His research, teaching and health planning expertise are based on substantial long term experience from working in rural and urban areas in Africa (mainly Tanzania, Chad, Burkina Faso and Côte d'Ivoire) and Asia (China, Thailand, Laos). He was co-investigator and coordinator of the first African malaria vaccine trial in 1992 and participated as co-principal investigator in several major intervention trials on malaria (iron supplementation, intermittent preventive treatment) and schistosomiasis. Besides research the capacity building and North-South partnership was a main interest as reflected in the development of the Ifakara Health Institute in Tanzania. He has published extensively in the many fields (>500 original papers). He also acts as advisor on communicable diseases research and control, health systems strengthening and capacity building in various national and international agencies/bodies and in boards/committees such as e.g. Wellcome Trust, DNDi, INCLEN-Trust, ISAB-COOP, NITD SAB.
Contact email@example.com for more information about this event.